Uncategorized
Glaukos establishes direct sales organization, launches iStent inject in Australia
Glaukos has established a direct sales organization and launched the iStent inject trabecular micro-bypass stent in Australia, according to a press release. The iStent inject was approved by the Therapeutic Goods Administration. It is to be used with cataract surgery to reduce IOP in patients with mild to moderate glaucoma who are being treated with ocular hypotensive medication.